VEGFA and neoplasm: The tumour architecture is a determinant of resistance to antiangiogenic therapy.29 Tumours in which nests of tumour cells are surrounded by well-developed stromal structures containing the majority of the vessels are less responsive to single therapies targeting VEGFA, compared with tumours in which the vessels are embedded in the tumour mass.